| Financial Year |
March 31 2023 |
| Monetary Funds |
569,212,584.01 |
| Held-for-trading Financial Assets |
166,515,850.08 |
| Notes Receivable |
202,698,456.37 |
| Accounts Receivable |
6,565,170,279.31 |
| Advances to Suppliers |
2,017,364,754.04 |
| Other Receivables |
466,179,545.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,791,989,063.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
239,547,241.11 |
| Total Current Assets |
16,426,603,634.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
7,816,547.48 |
| Fixed Assetes |
5,159,587,904.76 |
| Under-construction Projects |
469,386,064.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
536,234,421.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
78,947,162.76 |
| Deferred Income Tax Assets |
118,974,514.63 |
| Other Non-Current Assets |
142,899,991.36 |
| Sub-Total of Non-Current Assets |
6,530,586,347.25 |
| Total Assets |
22,957,189,982.16 |
| Short-Term Loans |
4,790,643,397.26 |
| Trading Financial liabilities |
27,584,760.55 |
| Notes Payable |
1,060,183,918.18 |
| Accounts Payable |
1,592,679,406.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
302,510,400.01 |
| Taxes Payable |
74,589,596.44 |
| Interest Payable |
-- |
| Dividend Payable |
333,720.30 |
| Other payables |
140,346,124.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,141,790,912.08 |
| Other Current Liabilities |
94,843,958.69 |
| Sub-Total of Current Liabilities |
9,561,692,485.05 |
| Long-term Loans |
3,528,250,000.00 |
| Bonds Payable |
1,355,966,008.05 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
193,219,429.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,505,871,879.23 |
| Total Liabilities |
15,067,564,364.28 |
| Paid-In Capital(Or Share Stock) |
1,479,908,180.00 |
| Capital Surplus |
1,937,697,150.64 |
| Surplus Reserve |
325,778,806.09 |
| LESS:Treasury Stock |
398,314,157.19 |
| Undistributed Profits |
3,739,064,778.89 |
| Minority Stockholder's Interest |
221,557,103.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,668,068,514.15 |
| Owner's Equity（Stockholder's Equity） |
7,889,625,617.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,957,189,982.16 |
